PRAX Praxis Precision Medicines Inc Total Business Assets
Praxis Precision Medicines (PRAX) is a leading developer of targeted therapies for CNS pathologies with a robust scientific and technical foundation in the fight against epilepsy. This price chart reflects total assets at 921.55. The operating model relies on an extensive network of external laboratories, which mitigates the risks of dependency on a single contractor. Simultaneously, Praxis Precision Medicines (PRAX) is building a foundation for long-term dominance by focusing on unique genetic brain modifications.
Analytical breakdowns and data insights for company Praxis Medicines (PRAX)
- stock quotes and analyst forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Praxis Precision Medicines|PRAX - Long-Term Debt to Equity|Current Liabilities to Capital Praxis Corp|PRAX - Company Debts|Debts to Book Capitalization Ratio Praxis Corp|PRAX - Company Long-Term Debt|Company Short-Term Loans and Borrowings Praxis Precision Medicines|Quick Ratio praxismedicines.com
- company profitability and valuation multiples indicators:
Basic company analysis:praxismedicines.com PRAX
Since Praxis Precision Medicines (PRAX) delegates drug production to third-party CMOs to focus on R&D, the value of total assets reflects the capitalization of intellectual and financial resources rather than physical plants. This indicator, reverse-calculated via ROA, digitizes the total value of assets and liabilities, where high line volatility signals instability in the capital base and elevated investment risks.
Main competitors
Total Business Assets BIIB|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|amylyx.com - Total Asset Value of Company|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|AVXL (Anavex) - Aggregate Asset Value|Company Total Assets CBLL (CeriBell Corp)|Company Total Assets Prothena PRTA|ALEC: Cumulative Company Assets|ANNX (annexonbio.com) - Total Business Assets|OMER: Company Total Assets|NGNE - Company Total Asset Base|Aggregate Company Assets AC Immune Corp|Voyager Corp (VYGR) - Company Total Asset Base|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Aggregate Asset Value|Aggregate Company Assets Tevogen Bio TVGN|ACOG (Alpha Cognition Inc) - Total Asset Value of Company|CGTX - Aggregate Company Assets|Aggregate Asset Value IKT (Inhibikase Pharma)|SAVA: Company Total Assets|Company Assets Assertio (ASRT)|COYA (Coya Therapeutics Inc) - Company Total Assets|Cumulative Company Assets VistaGen Therapeutics Inc (VTGN)|Company Total Assets OVID|Company Total Asset Base Acumen Pharmaceuticals, Inc|Aggregate Company Assets CervoMed Inc. CRVO|Company Total Asset Base Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Company Total Assets|Company Total Asset Base PepGen Inc. PEPG|Jupiter Neurosciences (JUNS) - Aggregate Company Assets|Company Assets Relmada Corp (RLMD)|Aggregate Company Assets Annovis Bio, Inc.|Total Business Assets GRCE (Grace Tx)|Cumulative Company Assets AIFF (Firefly Neuroscience)|KLTO (anewmeds.com) - Aggregate Asset Value|Aggregate Company Assets NeuroSense Therapeutics Ltd. NRSN|RVPH - Cumulative Company Assets|MetaVia, Inc. - Company Total Assets|Company Assets neuraxis.com|HSDT: Company Total Assets|Total Business Assets PASG|NEUP (Neuphoria Therapeutics, Inc.) - Company Total Assets|Minerva (NERV) - Company Total Asset Base|Company Total Assets ATHA|Cumulative Company Assets addextherapeutics.com ADXN|Company Total Assets ALZN (Alzamend Neuro)|Company Total Asset Base Cyclerion Therapeutics Inc. (CYCN)|PTIX - Aggregate Company Assets|KTTA (Pasithea Therapeutics) - Total Business Assets|CRGT: Company Total Assets|Company Assets avenuetx.com (ATXI)|Aggregate Company Assets BrainStorm Cell Therapeutics|Cara Therapeutics Inc. (CARA) - Company Total Asset Base|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|ELYM: Total Asset Value of Company|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|Aggregate Asset Value LBPH|Marinus Pharmaceuticals, Inc. - Company Total Assets|NKGN - Company Total Assets|NRBO (NeuroBo) - Cumulative Company Assets|Total Business Assets SAGE|Aggregate Company Assets Synaptogenix, Inc.|Total Business Assets TRVN (trevena.com)|Company Total Assets VIGL|WENA - Company Assets|Cerevel - Cumulative Company Assets